Recent research published in PLOS One revealed a key mechanism driving acute to chronic muscle pain and demonstrated how ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

Optimized treatment reduces the mortality risk associated with chronic heart failure, leading to improvements in both ...

A panelist discusses how axatilimab, a humanized IgG4 monoclonal antibody targeting CSF-1 receptors on monocytes and macrophages, showed promising results in the AGAVE-201 trial for ...

The DBA/2 mouse model is an inbred mouse strain in which young DBA/2 mice are susceptible to audiogenic seizures, making them a model for epilepsy studies. This epilepsy model does re-capitulate ...

Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...

However, these stocks also carry high risk, as their performance is heavily reliant on innovation, clinical trial success, ...

While many pharma and biotech companies developing drugs to treat Alzheimer's disease are targeting amyloid beta plaque, Eli ...

These drugs target some of the most pressing cancer types, including multiple myeloma, breast cancer, and bladder cancer ...

"Antihypertensive medication administration time did not affect the risks and benefits of blood pressure-lowering medication ...

Discover how increasing fiber intake naturally accelerates weight loss, reduces hunger, and improves metabolism without ...